5月19日 - ** Hoth Therapeutics（HOTH.O）股价在盘前交易中下跌12.8%，至53美分
** 该公司将更名为Rocket One Inc，并重组业务以寻求人工智能基础设施、新一代半导体技术及超低功耗人工智能计算领域的机遇
** 公司表示，凭借新获得的许可，将专注于“开发和商业化用于人工智能硬件加速及耐辐射计算应用的自旋电子计算技术”
** 称正考虑将生物技术资产剥离至一家独立的全资子公司
** 公司表示，此次业务转型已获得董事会一致批准
** 截至上一交易日收盘，该公司股价年内累计下跌38.1%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.